Below, we highlight the Inaugural 2025 Harrison Fellows who play an integral role in shaping the program’s impact.
Jennifer Berg (Texas, United States)
- Inaugural Harrison Fellow selected for the 2025–2026 Dr. Stephen A. Harrison Patient Advocacy Fellowship, representing patient advocacy in liver disease.
- Participates in a structured program to elevate patient voices in MASH and steatotic liver disease research and policy.
Jacki Chen (New Jersey, United States)
- Harrison Fellow in the inaugural cohort, contributing to patient-centered advocacy in liver disease.
- “Jacki Chen, PhD” also appears as a patient advocate involved in medical education activities related to hepatitis B care, stigma, and earlier treatment discussions.
Mark Curran (Massachusetts, United States)
- Named in the inaugural class of the Harrison Fellowship advancing patient leadership in liver disease.
- As a Fellow, likely engaged in training, networking with clinicians/researchers, and advocacy-focused activities.
Bruce D. Dimmig (Arizona, United States)
- Selected as a Harrison Fellow for the fellowship’s first cohort, representing liver disease patient advocacy.
- Participates in educational and leadership development tailored to MASH/SLD advocacy.
Lorrinda Gray-Davis (Texas, United States)
- Harrison Fellow and longtime transplant and liver advocacy leader; liver transplant recipient and president of Transplant Recipients International Organization (TRIO).
- Serves as Vice Chair of the Organ Procurement and Transplant Network (OPTN) Patient Affairs Committee and champions transplant equity and patient support.
Susan Horava (Ohio, United States)
- Included as an inaugural Harrison Fellow working to advance patient perspectives in liver disease care and research.
- Engages in the fellowship’s structured advocacy education and leadership pathways.
Marianthi Kavelidou (Massachusetts, United States)
- Named among the initial Harrison Fellows contributing to shaping liver disease research with patient insight.
- Likely involved in core fellowship activities including policy, regulatory literacy, and conference engagement.
Úna Keightley (Ireland)
- One of the inaugural Harrison Fellows, representing international patient advocacy from Ireland.
- Engages with global liver disease advocacy alongside the fellowship’s international cohort.
Silvana Lesidrenska (Bulgaria)
- Harrison Fellow bringing a European patient advocacy perspective to the cohort.
- Interviewed in external coverage as a liver patients association leader from Bulgaria focused on SLD advocacy and learning through the fellowship.
Kimberly Alice Martinez (Oklahoma, United States)
- Included in the inaugural Harrison Fellows advancing patient engagement in liver disease research and policy.
- Likely participating in networking and education opportunities central to the fellowship mission.
Pamela S. Miller (Ohio, United States)
- Harrison Fellow in the first cohort working to amplify patient voices in steatotic liver disease.
- Described in external coverage as a patient with MASH cirrhosis involved in clinical trials and legislative advocacy.
Lindsey Ruth Moore (North Carolina, United States)
- Named among the inaugural Harrison Fellows, contributing a regional patient advocacy perspective.
- Participates in the fellowship’s mentorship, education, and leadership development program.
Julie Peyaut (Canada)
- Harrison Fellow representing Canadian patient advocacy in the inaugural cohort.
- Profiled in external coverage as a MASH advocate with personal health experience shaping her advocacy.
Gabriela Portugal-Bouza (Utah, United States)
- Inaugural Harrison Fellow engaged in advancing patient engagement strategies in liver disease.
- Participates in fellowship activities including networking with researchers and policymakers.
Michele M. Radcliffe (California, United States)
- One of the inaugural Harrison Fellows working to elevate patient perspectives in research and clinical protocol discussions.
- As part of the cohort, receives training and mentorship to support patient advocacy leadership.
Kerry Marie Sivia (Illinois, United States)
- Harrison Fellow contributing to the fellowship’s mission of patient-centered liver disease advocacy.
- Likely engages in key conferences and educational modules provided through the program.
Melaine Smith (Kansas, United States)
- Included in the inaugural Harrison Fellowship cohort advancing patient insights into MASH and SLD.
- Coverage indicates she has lived with MASH cirrhosis and led support groups, informing her advocacy background.
Jennifer Thorp (Washington, United States)
- Named among the inaugural Harrison Fellows, helping bring patient experiences into liver disease research dialogues.
- Participates in the fellowship’s structured education, advocacy networking, and leadership activities.